Combination of proteasome and HDAC inhibitor enhances HPV16 E7-specific CD8(+) T cell immune response and antitumor effects in a preclinical cervical cancer model

Documenti analoghi

• Intratumoral injection of therapeutic HPV vaccinia vaccine following cisplatin enhances HPV-specific antitumor effects
  di: Lee, Sung Yong, et al.
  Pubblicazione: (2013)
• Histone Deacetylase Inhibitor AR-42 Enhances E7-Specific CD8+ T Cell-Mediated Antitumor Immunity Induced by Therapeutic HPV DNA Vaccination
  di: Lee, Sung Yong, et al.
  Pubblicazione: (2013)
• Treatment of Tumors with Vitamin E Suppresses Myeloid Derived Suppressor Cells and Enhances CD8+ T Cell-Mediated Antitumor Effects
  di: Kang, Tae Heung, et al.
  Pubblicazione: (2014)
• Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells
  di: Peng, Shiwen, et al.
  Pubblicazione: (2014)
• Combination of proteasome and HDAC inhibitors for therapy of uterine cervical cancer
  di: Lin, Zhenhua, et al.
  Pubblicazione: (2009)